Overview

Evaluating the Benefits of Personalized Traditional Chinese Medicine in Postoperative Treatment for Locally Advanced Colorectal Cancer

Status:
NOT_YET_RECRUITING

Trial end date:
2027-09-30

Target enrollment:

Participant gender:

Summary

This study aims to explore the role of Traditional Chinese Medicine (TCM) based on syndrome differentiation in reducing chemotherapy side effects, lowering the risk of metastasis and recurrence, and improving survival rates in postoperative colorectal cancer patients through a prospective, single-arm interventional clinical trial.

Phase:

PHASE2

Details

Lead Sponsor:

Sir Run Run Shaw Hospital

Treatments:

Medicine, Chinese Traditional
Palliative Care